The drugs work by mimicking the action of the glucagon-like peptide hormone involved in insulin sensitivity and the regulation of blood glucose
The durability of results after discontinuation remains unproven in humans
Research Background BPC-157 has been investigated in peer-reviewed studies examining FAK-paxillin signaling and associated cytoprotective mechanisms in cell culture and animal models
BPC-157 supports medical weight loss by improving gut health, which is crucial for effective nutrient absorption and metabolism
Chang KH, PhD, Zal T, PhD, MSc, Basyal M, BSc, Ostermann L, Muftuoglu M, MD, Mak PY, Jia Y, Tao W, Zal MA, MSc, Fogler WE, PhD, Magnani JL, PhD, Zhang W, MD, PhD, Carter BZ, PhD, Andreeff M , MD, PhD